KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UiPath (PATH) Research & Development (2020 - 2026)

UiPath (PATH) has disclosed Research & Development for 6 consecutive years, with $96.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development changed 0.11% year-over-year to $96.9 million, compared with a TTM value of $389.7 million through Oct 2025, up 9.36%, and an annual FY2025 reading of $380.7 million, up 14.63% over the prior year.
  • Research & Development was $96.9 million for Q4 2025 at UiPath, down from $98.3 million in the prior quarter.
  • Across five years, Research & Development topped out at $99.7 million in Q1 2025 and bottomed at $29.2 million in Q1 2021.
  • Average Research & Development over 5 years is $79.2 million, with a median of $85.6 million recorded in 2024.
  • The sharpest move saw Research & Development skyrocketed 248.09% in 2021, then fell 26.17% in 2022.
  • Year by year, Research & Development stood at $61.6 million in 2021, then rose by 10.22% to $67.8 million in 2022, then increased by 11.04% to $75.3 million in 2023, then rose by 28.71% to $97.0 million in 2024, then decreased by 0.11% to $96.9 million in 2025.
  • Business Quant data shows Research & Development for PATH at $96.9 million in Q4 2025, $98.3 million in Q3 2025, and $94.8 million in Q2 2025.